Crown Equity Holdings Inc. (OTCBB:CRWE.OB) is a company utilizing today’s technology to advertise, promote and market public companies globally.
Crown Equity announced that its subsidiary company, Crown Tele Services Inc. is still moving forward after dissolving its joint venture with Communication Expert Corporation and will gradually start rolling out its internet based voice and video service IP-PBX solutions next year.
Hosted IP-PBX lets you share a number of incoming phone lines among a larger number of extensions, so it's not necessary to pay for a separate line for every office employee or workstation, which saves money. But the implementation and ongoing maintenance of an VOIP PBX system requires a type of expertise that your IT staff may not have. And if you go with a commercial product, the up-front costs for the hardware and software may be high.
Crown Equity Holdings Inc., together with its digital network, currently provides electronic media services specializing in online publishing and Web sites, which bring together targeted audiences and advertisers that want to reach them. Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.
Crown Equity Holdings Inc. announced in June of this year its 1- 10 forward stock split, as well as in August announcing that the company had surpassed One Million dollars (1,000,000) in sales.
CRWE reported its financial results for the nine month period ending September 30, 2010. Revenue for the nine months totaled $1,073,383 compared to $418,959 during 2009.
"Our continued progress in operations including an operating profit of $7,251 during the last quarter shows a continued growth in our business," commented Kenneth Bosket, President and CEO of Crown Equity Holdings Inc. "Not only do our financial results show strong growth during this year but our continued investment in infrastructure will support our future growth," stated Bosket.
Crown Equity Holdings Inc. is extending its internet footprint internationally to include the following countries; Argentina, Brazil, Canada, China, France, Germany, Hong Kong, India, Indonesia, Italy, Japan, Korea, Malaysia, Mexico, New Zealand, Pakistan, Russia, Singapore, Spain, South Africa, Taiwan, United Arab Emirates and United Kingdom.
Companhia de Saneamento Basico do Estado de Sao Paulo (NYSE:SBS) announced the Pricing of its 6.250% Notes Due 2020.SBS one of the largest water and sewage services providers in the world based on the number of customers, in compliance with CVM Instruction no. 358 of January 3, 2002, issued by the Brazilian Securities Commission (Comissao de Valores Mobiliarios – CVM), discloses to its shareholders and to the market in general, the pricing for its 6.250% Notes Due 2020 ("Notes"), in the principal amount of US$350,000,000, to be placed outside of Brazil to certain qualified institutional investors. The proceeds from the offering of the Notes will be used to repay certain outstanding indebtedness of SABESP.
Companhia de Saneamento Basico do Estado de Sao Paulo provides basic and environmental sanitation services and sewage treatment services, as well as supplies treated water in the state of Sao Paulo. It offers water and sewage services to residential, commercial, industrial, and governmental customers in 366 municipalities; and supplies water on a wholesale basis to 6 municipalities.
Arch Chemicals Inc (NYSE:ARJ) called on American companies and workers to encourage Congress to ratify the Korea-United States Free Trade Agreement. Trade officials from both countries just announced that they have come to terms on issues that have held up ratification of this agreement for almost three years."This is the largest free trade agreement since NAFTA, and it will provide significant economic benefits for both countries," said Mr. Campbell. "It is of particular significance for the United States because the increase in U.S. exports to Korea will provide jobs for thousands of American workers, just when jobs must be the most important focus of U.S. economic policy."
Arch Chemicals, Inc., a biocides company, provides chemistry-based and related solutions to destroy and control the growth of harmful microbes in the United States and internationally. It operates in two segments, Treatment Products and Performance Products. The Treatment Products segment manufactures and sells water treatment chemicals for the sanitization and treatment of residential and commercial pool and spa water, drinking water, surface water.
InterOil Corporation (NYSE:IOC) announced that it has been granted Petroleum Retention License (PRL) No. 15, covering blocks including and surrounding the Elk and Antelope fields, unifying the fields into a single license separate from our exploration acreage and specifying minimum work commitment activities over the next five years.Phil Mulacek, CEO of InterOil, commented: "Grant of the PRL demonstrates commitment from the Government of PNG emanating from our past record, as well as confidence in InterOil's forward capabilities. Furthermore, the PRL organizes the fields in a way that will be helpful for partnering while allowing us to advance our condensate and LNG plans."
InterOil Corporation, together with its subsidiaries, primarily engages in the exploration and production of oil and gas properties in Papua New Guinea. The company holds interests in four petroleum prospecting licenses covering approximately 4.7 million gross acres in Papua New Guinea. It also involves in the refining and liquefaction of jet fuel, diesel, and gasoline, as well as naphtha and low sulfur waxy residue.
Alzheimer's disease is among the most well known form of dementia, a broad term when it comes to forgetfulness and other intellectual abilities critical enough to obstruct everyday life. Alzheimer's diseases is the reason for 50 to seventy per cent of dementia cases.
Power3 Medical Products Inc (OTCBB:PWRM.OB) is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroProÂ®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
PWRM delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro, Power3’s diagnostic test, and focused on PWRM ’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.
President and Chief Scientific Officer of Power3,Dr. Ira L. Goldknopf, commented: “In preparation for commercialization, our objective at this meeting was to show how Power3’s protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer’s disease. It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which PWRM’s protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs.”
PWRM has filed several patent applications for its NuroPro technology that are currently pending. PWRM also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, PWRM has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. PWRM intends to publish these latest findings as well.
More about PWRM at: www.Power3Medical.com
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. BestOtc.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://bestotc.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold BestOTC.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).